Provided by Tiger Trade Technology Pte. Ltd.

Lexicon Pharmaceuticals

2.16
-0.0700-3.14%
Post-market: 2.210.0500+2.31%19:47 EDT
Volume:1.63M
Turnover:3.57M
Market Cap:959.04M
PE:-30.85
High:2.29
Open:2.23
Low:2.16
Close:2.23
52wk High:2.53
52wk Low:0.6150
Shares:444.00M
Float Shares:418.00M
Volume Ratio:0.87
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0700
EPS(LYR):-0.1387
ROE:-16.01%
ROA:-5.35%
PB:4.73
PE(LYR):-15.58

Loading ...

Company Profile

Company Name:
Lexicon Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
1995
Employees:
81
Office Location:
2445 Technology Forest Boulevard,11th Floor,The Woodlands,Texas,United States
Zip Code:
77381
Fax:
281 863 8088
Introduction:
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.

Directors

Name
Position
Michael S. Exton
Chief Executive Officer and Director
Raymond Debbane
Chairman of the Board and Independent Director
Christopher J. Sobecki
Independent Director
Diane E. Sullivan
Independent Director
Ivan H. Cheung
Independent Director
Judith L. Swain
Independent Director
Philippe J. Amouyal
Independent Director
Samuel L. Barker
Independent Director

Shareholders

Name
Position
Michael S. Exton
Chief Executive Officer and Director
Brian T. Crum
Senior Vice President and General Counsel
Craig B. Granowitz
Senior Vice President and Chief Medical Officer
Lisa M. DeFrancesco
Senior Vice President, Investor Relations and Corporate Communications
Rachel Y. Martens
Senior Vice President, Partnerships and Corporate Strategy
Scott M. Coiante
Senior Vice President and Chief Financial Officer
Suma Gopinathan
Senior Vice President, Discovery
Wendy E. McDermott
Senior Vice President, Human Resources